Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria.
| Autor: | Jeeyapant, Atthanee1, Kingston, Hugh W.1,2,3, Plewes, Katherine1,3, Maude, Richard J.1, Hanson, Josh1,4, Herdman, M. Trent1,5, Leopold, Stije J.1, Ngernseng, Thatsanun1, Charunwatthana, Prakaykaew1,6, Phu, Nguyen Hoan7, Ghose, Aniruddha8, Hasan, M. Mahtab Uddin8, Fanello, Caterina I.1,9, Faiz, Md Abul1,10, Hien, Tran Tinh7, Day, Nicholas P. J.1,3, White, Nicholas J.1,3, Dondorp, Arjen M.1,3 arjen@tropmedres.ac |
|---|---|
| Zdroj: | PLoS ONE. 1/4/2017, Vol. 12 Issue 1, p1-15. 15p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|